A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(1 site)
United States
Virginia Mason Medical Center, Seattle, Washington Age range
18 Years – 65 Years
Last updated September 2024